Cigna Group vs Altria

Side-by-side comparison of AI visibility scores, market position, and capabilities

Altria leads in AI visibility (90 vs 28)

Cigna Group

EmergingTechnology

General

Integrated health insurer and PBM with $230B revenue; Express Scripts pharmacy management plus Cigna Healthcare employer and Medicare Advantage plans.

AI VisibilityBeta
Overall Score
D28
Category Rank
#727 of 1167
AI Consensus
72%
Trend
stable
Per Platform
ChatGPT
38
Perplexity
30
Gemini
29

About

Cigna Group is a global health services company providing medical, pharmacy, behavioral health, dental, disability, and life insurance products and services to employers, government programs, and individuals. Headquartered in Bloomfield, Connecticut, Cigna operates through two major segments: Evernorth Health Services (pharmacy benefit management via Express Scripts, specialty pharmacy, and care delivery) and Cigna Healthcare (commercial and government medical plans). The company is listed on the NYSE and generates approximately $230 billion in annual revenue, making it one of the largest healthcare companies in the US.

Full profile

Altria

LeaderConsumer Goods

Enterprise

Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.

AI VisibilityBeta
Overall Score
A90
Category Rank
#83 of 290
AI Consensus
58%
Trend
stable
Per Platform
ChatGPT
84
Perplexity
97
Gemini
99

About

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.

Full profile

AI Visibility Head-to-Head

28
Overall Score
90
#727
Category Rank
#83
72
AI Consensus
58
stable
Trend
stable
38
ChatGPT
84
30
Perplexity
97
29
Gemini
99
32
Claude
86
39
Grok
87

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.